O. V. Filon

Phase 3 Trial of Coronavir (Favipiravir) in Patients with Mild to Moderate COVID-19

P. V. Chukhliaev, Rodion A Oseshnyuk, Tatyana N Soluyanova et al. · SSRN Electronic Journal · 2020 · 27 citations · Full text

Phase 3 trial of coronavir (favipiravir) in patients with mild to moderate COVID-19.

Rodion A Oseshnyuk, Tatyana N Soluyanova, Elena Petrovna Dmitrikova et al. · PubMed · 2021 · 18 citations · Full text

Efficacy and safety of BCD-021, bevacizumab biosimilar candidate, compared to Avastin: Results of international multicenter randomized double blind phase III study in patients with advanced non-squamous NSCLC.

O. V. Filon, Sergey Orlov, Olga Burdaeva et al. · Journal of Clinical Oncology · 2015 · 16 citations

Pharmacotherapy, Comprehensive Comparability Exercise, International Multicenter +19

A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.

O. V. Filon, Petr Krivorotko, Grigory Kobyakov et al. · Journal of Clinical Oncology · 2017 · 15 citations

E13537 Background, Nanotherapeutics, High-grade Gliomas +21

Pharmacokinetics and safety of BCD-021, bevacizumab biosimilar candidate, compared to Avastin in patients.

Sergey Orlov, Olga Burdaeva, Marina P. Nechaeva et al. · Journal of Clinical Oncology · 2014 · 13 citations

Pharmacotherapy, Bevacizumab Biosimilar Candidate, Pre-clinical Pharmacology +16